Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
caffeine (3 trials)
darbepoetin alfa (aranesp) (1 trial)
sitagliptin (januvia) (1 trial)
atorvastatin (lipitor) (1 trial)
3bnc117 (1 trial)
romidepsin (istodax) (1 trial)
semaglutide (Ozempic) (2 trials)
acetylsalicylic acid (aspirin) (1 trial)
dexamethasone (1 trial)
estrogen (1 trial)
finerenone (KERENDIA) (1 trial)
potassium chloride (klor-con) (1 trial)
potassium nitrate (1 trial)
prednisolone (hydeltra) (1 trial)
sodium chloride (1 trial)
sotagliflozin (Inpefa) (1 trial)
vitamin d3 (1 trial)
Breast Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 4)
Intermittent Claudication (Phase 3)
Polycystic Ovary Syndrome (Phase 4)
Syndrome (Phase 4)
Trials (14 total)
Trial APIs (17 total)